UHS Chemotherapy Adjuvant

Novel Macromolecular Targeted Chemoprotective PreparationThis breakthrough macromolecular agent is engineered for systemic protection and efficacy enhancement during solid tumor chemotherapy. Versatile Delivery: Supports oral administration (crosses the gastrointestinal barrier, bypassing hepatic first-pass degradation), IV, and subcutaneous injection. Clinical Indications: Specifically antagonizes chemotherapy-induced toxicities in parenchymal organs (cardiac, hepatorenal, auditory), repairs the blood-brain barrier to alleviate neuropathy, and arrests bone marrow senescence to mitigate severe suppression. Dual Mechanism: * Healthy Tissue Shield: Provides spatial isolation and neutralizes free radicals to protect normal cells. - Microenvironment Remodeling: Inhibits cancer stem cell metabolism and lifts immunosuppression without compromising chemotherapeutic lethality. Core Advantages: Features high specificity with minimal off-target rates and stable pharmacokinetics. The molecular conformation is robust, supporting high-temperature sterilization and long-term cold-chain storage with excellent multi-drug compatibility.Currently seeking co-development with pharmaceutical companies.E-mail: [e-mail]